05 Dec Aptamers Market: by Aptamers Type, Application and End Users. Key Players are Neoventures Biotechnology Inc., Aptagen LLC, Somalogic, and AM Biotechnologies, LLC.
Precision Business Insights (PBI) in its report titled “Global Aptamers Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025” assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Market boosts and restraining factors
Factors such rise in the investment in biotechnology and pharmaceutical companies for R&D activities, technological developments, and an increase in the therapeutic application anticipated to fuel the aptamers market over the forecast period. Furthermore, increase in the using of aptamers in drug discovery, entry of private organizations in R &D space, and advantages of aptamers over other therapeutics expected to drive the aptamers market.
However, stringent regulatory policies and ethical issues in aptamers usage, dearth of aptamers in the market in the undeveloped regions, and lack of awareness about the aptamers usage expected to dampen the growth of aptamers market.
The global aptamers market is segmented on the basis of aptamers type, application, and end users.
A sample of this report is available upon request @
North America leads the top position in the global aptamers market
North America is expected to hold a dominant share in aptamers market owing to technological advancements, a rise in collaboration of biopharmaceutical companies for R&D activities, and favourable government regulations for clinical trials.
Europe has a significant growth in aptamers market owing to the adoption of developed aptamer technologies and an increase in the preference for aptamer-based treatment.
Asia Pacific has shown lucrative growth over the forecast period owing to increase in the incidence of chronic diseases, rise in demand for cost-effective treatment, increase in healthcare expenditure, and adoption of novel technologies majorly in Japan and China are the factors expected to boost the aptamers market in the region.
Technological advancements and strategic alliances are the key strategies adopted by market players
Aptamers market is the growing stage with an increase in R&D activities by the various biopharmaceutical companies and research institutes. Technological advancements and drug innovations are expected to fuel the aptamers market.
Acquisitions and mergers, collaborations, newer technologies launches, fundraising for aptamers development and patent approvals are some key strategies adopted by the companies to increase their share in the global aptamers market.
For instance, in February 2016, researchers from Institute of Bioengineering and Nanotechnology (Singapore) have developed more efficient DNA technology for detection and treatment of cancer and infectious diseases.
Customisation of this report is available upon request @
Some of the players in Aptamers market are
- NeoVentures Biotechnology, Inc. (Canada)
- Aptagen, LLC (U.S.)
- Aptamer Solutions Ltd. (U.K.)
- SomaLogic, Inc. (U.S.)
- AM Biotechnologies, LLC (U.S.)
- TriLink BioTechnologies, Inc. (U.S.)
- Vivonics, Inc. (U.S.)
- Apta Targets (Spain)
Notable market development:
In May 2017, AptaTargets raised € 2.7 Mn funding from Caixa Capital Risc for the development of clinical trials for ApTOLL, a drug used in the treatment of acute ischemic stroke.
Need more information about this report @
By aptamers type
- Nucleic acid aptamers
- Peptide aptamers
- Research & Development
- Therapeutic development
- Pharmaceutical companies
- Biopharmaceutical companies
- Research and academic institutes
By geographical regions
- North America
- Latin America
- The Middle East & Africa
Get access to full summary @
About Precision Business Insights:
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
152 – 160 City Road,
London EC1V 2NX
Toll Free (US):+1-866-598-1553